利用SIRT1激活剂进行有效的PCOS治疗:一个新的前沿
Shreyash Rajendra Moharir1, Mahesh Kumar Talamadla1, Puja Bhardwaj2
1Department of Chemistry, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Hyderabad, Telangana 500078, India.
概括
多囊卵巢综合征 (PCOS) 涉及SIRT1失调,影响胰岛素抵抗和炎症. 激活SIRT1为PCOS管理提供了一个潜在的治疗策略.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 多囊卵巢综合征 (PCOS) 是一种常见的内分泌疾病,影响生殖和代谢功能.
- Sirtuin 1 (SIRT1) 是一种依赖NAD+的脱乙酶,在细胞代谢和应激反应中起作用.
- 对SIRT1的调节失调与PCOS的病理生理学有关.
研究的目的:
- 审查SIRT1和PCOS之间的相关性.
- 阐明将SIRT1与PCOS联系在一起的机制,包括胰岛素耐药性,氧化应激,炎症和自.
- 讨论SIRT1激活剂作为PCOS潜在治疗剂的化学结构和作用.
主要方法:
- 对SIRT1和PCOS研究的文献综述.
- 在PCOS中涉及SIRT1的分子机制的分析.
- 审查现有的天然和合成SIRT1激活剂及其化学特性.
主要成果:
- 在PCOS中,SIRT1经常下调,导致胰岛素耐药性和其他代谢障碍.
- 通过关键转录因子的脱乙基化,SIRT1激活可以改善PCOS相关的病理.
- 各种天然和合成化合物具有SIRT1激活特性,具有潜在的治疗应用.
结论:
- SIRT1是PCOS干预的关键分子标.
- 向SIRT1激活为管理PCOS及其相关代谢并发症提供了一个有希望的治疗途径.
- 对SIRT1激活剂的进一步研究可能会导致新的PCOS治疗方法.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
305
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
305
Hormonal Control of the Ovarian Cycle
3.0K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
3.0K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K


